| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.28 | 9e-17 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-15 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.28 | 9e-15 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-14 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-12 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-10 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-09 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.2 | 6e-09 |